Acp-103-047
ClinicalTrials.gov NCT03623321
Research payments
$1,278,564
Through program year 2023, $1,278,564 in research payments was reported against Acp-103-047, across 88 payments, paid by ACADIA Pharmaceuticals Inc.
- Paid by
- ACADIA Pharmaceuticals Inc
- ClinicalTrials.gov
- NCT03623321
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $1,005,327 | 70 |
| 2022 | Research | $273,237 | 18 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mark Hernandez Hialeah, FL Named on 13 payments
- Aniel Navarro Marin Miami, FL Named on 12 payments
- Evelio Sosa Miami, FL Named on 9 payments
- Heber Varela Miami, FL Named on 8 payments
- Kenia Castro Hialeah, FL Named on 7 payments
- Monica Crane Knoxville, TN Named on 5 payments
- Pilar Trueba Doral, FL Named on 5 payments
- Gustavo Alva Costa Mesa, CA Named on 4 payments
- Miguel Perez Hialeah, FL Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.